0
Skip to Content
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Guest Posts
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Launch of the Psychedelic Access and Research European Alliance

Next

Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality

You Might Also Like

Related Video Item Thumbnail Francisca Silva - Development and delivery of psychedelic therapies in European healthcare | Associazione Luca Coscioni hybrid event
Related Embedded Video Item Thumbnail PAREA: psychedelic-assisted therapies in Europe
Related Embedded Video Item Thumbnail PSYCH Symposium: The Future of Psychedelic Medicine in the EU
Related Embedded Video Item Thumbnail Launch of the Psychedelic Access and Research European Alliance
Related Embedded Video Item Thumbnail PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – Tadeusz Hawrot

Our Work

About
Why

Contact

tadeusz@parea.eu

© Parea 2024 | Privacy Policy